Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Squamous Cell (Phase 3)

Cardiotoxicity (Phase 2)

Colorectal Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 2)

Head and Neck Neoplasms (Phase 3)

HIV Infections (Phase 2)

Laryngeal Diseases (Phase 2)

Laryngeal Neoplasms (Phase 2)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Leukemia, Lymphoid (Phase 3)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Chronic-Phase (Phase 1)

Leukemia, Myelomonocytic, Acute (Phase 2)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Leukemia, Myelomonocytic, Juvenile (Phase 2)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 3)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Large-Cell, Anaplastic (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Lymphoma, T-Cell (Phase 2)

Multiple Myeloma (Phase 2)

Nausea (Phase 3)

Neoplasms (Phase 3)

Neoplasms, Plasma Cell (Phase 2)

Oropharyngeal Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 3)

Stomach Neoplasms (Phase 2)

Triple Negative Breast Neoplasms (Phase 2)

Vomiting (Phase 3)